Jamjoom Pharma 9M 2024 profit up 23% to 304.9M; Q3 at SAR 95M
View other reports
Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) posted a net profit of SAR 304.9 million in 9M 2024, leaping 23% from SAR 247.9 million a year earlier.
Financials (M)
| Item | 9m 2023 | 9m 2024 | Change |
|---|---|---|---|
| Revenues | 891.86 | 1,058.77 | 18.7 % |
| Gross Income | 584.93 | 661.99 | 13.2 % |
| Operating Income | 271.14 | 326.52 | 20.4 % |
| Net Income | 247.92 | 304.92 | 23.0 % |
| Average Shares | 70.00 | 70.00 | - |
| EPS (Riyals) | 3.54 | 4.36 | 23.0 % |
The profit increase was buoyed by 18.7% revenue growth year-on-year (YoY) due to higher sales volume in main markets, price adjustment for some products, new product launches, cost management efficiency, and the return on investment in Algeria.
Current Quarter Comparison (M)
| Item | Q3 2023 | Q3 2024 | Change |
|---|---|---|---|
| Revenues | 292.61 | 327.58 | 11.9 % |
| Gross Income | 187.23 | 194.41 | 3.8 % |
| Operating Income | 84.67 | 95.67 | 13.0 % |
| Net Income | 77.25 | 94.99 | 23.0 % |
| Average Shares | 70.00 | 70.00 | - |
| EPS (Riyals) | 1.10 | 1.36 | 23.0 % |
The third-quarter earnings jumped 23% to SAR 95 million, compared to SAR 77.25 million in the year-ago period.
On a quarterly basis, the company posted an 11.2% decline in Q3 profit from SAR 106.95 million.
Shareholders’ equity, no minority interest, increased to SAR 1.44 billion as of Sept. 30, 2024, compared to SAR 1.36 billion a year earlier.
Attached Documents
Financial results (Million)
| Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
|---|---|---|---|---|---|---|
| Q1 2024 | 385.46 | 28.1 % | 249.40 | 24.9 % | 126.58 | 34.8 % |
| Q2 2024 | 345.74 | 15.9 % | 218.18 | 10.1 % | 104.26 | 12.6 % |
| Q3 2024 | 327.58 | 11.9 % | 194.41 | 3.8 % | 95.67 | 13.0 % |
Profit Performance (Million)
| Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
|---|---|---|---|---|---|---|
| Q1 2024 | 102.97 | 22.0 % | 1.47 | - | 102.97 | 1.47 |
| Q2 2024 | 106.95 | 24.0 % | 1.53 | - | 106.95 | 1.53 |
| Q3 2024 | 94.99 | 23.0 % | 1.36 | - | 94.99 | 1.36 |
Profitability
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2024 | 63.63 % | 31.58 % | 26.26 % |
| Q2 2024 | 62.82 % | 31.59 % | 26.93 % |
| Q3 2024 | 61.65 % | 31.83 % | 27.59 % |
Per Share Data (Riyal)
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2024 | 70.00 | 4.44 | 4.44 | 20.88 |
| Q2 2024 | 70.00 | 4.74 | 4.74 | 20.90 |
| Q3 2024 | 70.00 | 4.99 | 4.99 | 20.64 |
Multiple Ratios (End of Period Price)
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| Q1 2024 | 28.59 | 28.59 | 6.08 |
| Q2 2024 | 30.69 | 30.69 | 6.96 |
| Q3 2024 | 38.19 | 38.19 | 9.24 |
Business Segments (Million)
Q3 2024
| Period | Pharmaceutical products | Consumer Health Products |
|---|---|---|
| Q1 2024 | 334.33 | 51.13 |
| Q2 2024 | 299.43 | 46.30 |
| Q3 2024 | 282.33 | 45.24 |
Analysts Estimates (Million)
| Item | Q3 2024 (e) | Q3 2024 (a) | Change |
|---|---|---|---|
| Average | 98.54 | 94.99 | (3.6 %) |
Estimates vs Actual (Million)
| Item | Q3 2024 (e) | Q3 2024 (a) | Change |
|---|---|---|---|
| Al Rajhi Capital | 91.00 | 94.99 | 4.4 % |
| United Securities Company | 100.00 | 94.99 | (5.0) % |
| OSOOL AND BAKHEET | 101.16 | 94.99 | (6.1) % |
| GIB Capital | 102.00 | 94.99 | (6.9) % |
| Current | |
| Market Cap (M Riyal) | 10,976.00 |
| Enterprise Value (EV) (M) | 10,854.18 |
| Shares Outstanding ((M)) | 70.00 |
| EPS ( Riyal) (TTM) | 4.99 |
| Book Value (BV) ( Riyal) | 20.64 |
| Par Value ( Riyal) | 10.00 |
| Adjusted P/E (Last12) | 31.41 |
| P/E (TTM) | 31.41 |
| Price/book | 7.60 |
| Return on Average Assets (%) (TTM) | 19.9 |
| Return on Average Equity (%) (TTM) | 24.9 |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}